Since STAT4 and STAT6 expression is inversely regulated in CTCL, the loss of STAT4 can be both a potent diagnostic tool for leukemic CTCL/SS and a poor prognostic marker for early MF [23]. The gene discussed is STAT6; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.